DouYu International Holdings Limited ADS (DOYU) Next Earnings Date & Expected ±10.9% Move

Per the Roarable RQD rating, DOYU scores 22 out of 100, earning a letter grade of E and the verdict label "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars break down as follows:

• Fundamental Cash Engine: 6 / 20. The pillar reflects an ROIC of 1.6% and an FCF yield of -6.82%. For an investor, this means the business is not currently generating returns meaningfully above what it spends to operate, and free cash flow is negative relative to the share price.
• Whale 13F Flow: 3 / 20. This pillar reflects institutional accumulation and options positioning. The source data does not provide 13F holdings detail, so the low score indicates weak institutional support rather than a specific filing-level picture.
• Insider Conviction: 3 / 20. This pillar reflects SEC Form 4 and Congressional PTR cluster flow. The low score signals limited evidence of insider conviction in the stock.
• Macro Regime Fit: 3 / 20. This pillar reflects a beta of 1.0 and sector sensitivity. A beta of 1.0 implies market-level sensitivity, and the low pillar score signals that the regime-fit assessment does not favor the stock.
• Forensic Balance Sheet: 7 / 20. This pillar reflects an Altman Z-Score of 0.5, a Piotroski F-Score of 1/9, and a Debt/Equity ratio of 0.5. The Altman and Piotroski readings are the most significant forensic warnings in the source data.

For a prospective investor evaluating the stock today, these facts point toward elevated risk: weak cash generation, minimal institutional and insider support, and forensic warning signals. The valuation tradeoff is that the stock trades at a price of 3.65 with an EV/EBITDA of 77, which the source data presents without a P/E or EPS anchor to contextualize it. The verdict label itself is the source's assessment and should be weighed alongside these underlying metrics.

Per the SEC financials, revenue declined from $778.9M in FY 2023 to $585.1M in FY 2024 and to $546.1M in FY 2025. Operating income was $-23.1M, $-78.6M, and $0.7M across the same periods, with the company reaching a marginally positive operating result only in FY 2025. Reported net income is $0.0M in each period, and free cash flow was negative in all three years. Per the market data, the gross margin is 12.8%, the operating margin is 0.1%, the net margin is 0%, and ROIC is 1.6%. The Altman Z-Score is 0.5 and the Piotroski F-Score is 1/9, both per the Roarable RQD rating, indicating financial stress signals; the Debt/Equity ratio is 0.5, and cash was $251.6M in FY 2025, while debt is N/A for the reported periods.

• What are DOYU's products, customers, and revenue model, given that the source data does not describe the business?
• What drove the decline in revenue across FY 2023 to FY 2025, and what is the company's outlook for the top line?
• What are the company's debt obligations, since debt is N/A in every reported period despite a Debt/Equity ratio of 0.5?
• Why are EPS and P/E (TTM) unavailable, and how should the EV/EBITDA of 77 be interpreted without earnings context?
• What explains the 52-week range of $3.42 to $7.23 relative to the current price of 3.65?